A small molecule that blocks TYK2 in the brain showed promise for reducing disease activity in mouse models of multiple ...
Columnist Desiree Lama remembers how a best friend helped her with stressful assignments and RRMS symptoms in college.
MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...
People with multiple sclerosis (MS) may receive less frequent infusions of rituximab without increasing their chances of relapse or disease progression, according to a real-world study from Norway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback